Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
40,150
Total Claims
$2.9M
Drug Cost
1,427
Beneficiaries
$2,065
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-98%
Opioid rate vs peers
0.0% vs 2.2% avg
+46%
Cost per patient vs peers
$2,065 vs $1,411 avg
+76%
Brand preference vs peers
18.7% vs 10.6% avg
Brand vs Generic
Brand: 7,464 claims · $2.0M
Generic: 32,506 claims · $980K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,752 | $501K |
| Insulin Glargine,hum.Rec.Anlog | 413 | $70K |
| Sitagliptin Phosphate | 247 | $67K |
| Dulaglutide | 107 | $62K |
| Fluticasone/Vilanterol | 142 | $50K |
| Memantine Hcl | 630 | $46K |
| Insulin Glargine,hum.Rec.Anlog | 146 | $46K |
| Fluticasone/Umeclidin/Vilanter | 89 | $44K |
| Rifaximin | 31 | $44K |
| Rivaroxaban | 161 | $43K |
| Mirabegron | 178 | $42K |
| Potassium Chloride | 887 | $41K |
| Sacubitril/Valsartan | 106 | $40K |
| Dimethyl Fumarate | 11 | $39K |
| Tiotropium Bromide | 75 | $34K |
Prescribing Profile
Patient Profile
77
Avg Age
66%
Female
2.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data